Nucleoside analogues and HIV: The combined cost to mitochondria

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 5, 2003, Pages 1091-1093

  Cherry, Catherine L ^a,b,c   Wesselingh, Steven L ^a,b,c  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c BURNET INSTITUTE   (Australia)

Author keywords

HIV; Mitochondria; Nucleoside analogue

Indexed keywords

ABACAVIR; ACETYLCARNITINE; ANTIRETROVIRUS AGENT; DIDANOSINE; DNA POLYMERASE; LAMIVUDINE; MITOCHONDRIAL DNA; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; UBIDECARENONE; VIRUS DNA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; DRUG MECHANISM; DRUG METABOLISM; FATTY LIVER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; LACTIC ACIDOSIS; LIPOATROPHY; MEGALOCYTOSIS; METABOLIC DISORDER; MITOCHONDRIAL MYOPATHY; MITOCHONDRION; MORBIDITY; MORTALITY; MYOPATHY; NONHUMAN; PANCREATITIS; PERIPHERAL NERVE INJURY; SENSORY NEUROPATHY; VIRUS INHIBITION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, MITOCHONDRIAL; HIV; HIV INFECTIONS; HUMANS; MITOCHONDRIA;

EID: 0037764106     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg203     Document Type: Article

References (23)

1. Palella, F., Delaney, K., Moorman, A., Loveless, M., Fuhrer, J., Satten, G. et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine 338, 853-60.
2. Brinkman, K., ter Hofstede, J., Burger, D., Smeitink, J. & Koopmans, P. (1998). Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12, 1735-44.
3. Brinkman, K., Smeitink, J., Romijn, J. & Reiss, P. (1999). Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354, 1112-5.
4. Lewis, W. & Dalakas, M. (1995). Mitochondrial toxicity of antiviral drugs. Nature Medicine 1, 417-22.
5. Chen, C., Vazquez-Padua, M. & Cheng, Y. (1991). Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Molecular Pharmacology 39, 625-8.
6. Simon, D. & Johns, D. (1999). Mitochondrial disorders: clinical and genetic features. Annual Review of Medicine 50, 111-27.
7. Kakuda, T. (2000). Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clinical Therapeutics 22, 685-708.
8. Stein, D. E. & Moore, K. H. (2001). Phosphorylation of nucleoside analog antiretrovirals: a review for clinicians. Pharmacotherapy 21, 11-34.
9. Hammond, E. L., Sayer, D., Nolan, D., Walker, U. A., de Ronde, A., Montaner, J. S. et al. (2002). Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study. Journal of Clinical Virology, in press.
10. Shikuma, C. M., Hu, N., Milne, C., Yosi, F., Waslien, C., Shimizu, S. et al. (2001). Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS 15, 1801-9.
11. Cote, H. C., Brumme, Z. L., Craib, K. J., Math, M., Alexander, C. S., Wynhoven, B. et al. (2002). Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. New England Journal of Medicine 346, 811-20.
12. Cherry, C., Gahan, M., Lewin, S., McArthur, J. & Wesselingh, S. (2002). Treatment with dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. Journal of Acquired Immune Deficiency Syndrome 30, 271-7.
13. Cherry, C. L., Nolan, D., James, I., Mallal, S., French, M., Hammond, E. L. et al. (2003). Longitudinal associations between antiretroviral treatments and quantification of tissue mitochondrial DNA from ambulatory subjects with HIV infection. In Tenth Conference on Retroviruses and Opportunistic Infections, Boston, MA, USA.
14. Chattha, G., Arieff, A. I., Cary, C. & Tierney, L. M. (1993). Lactic acidosis complicating the acquired immunodeficiency syndrome. Annals of Internal Medicine 118, 37-9.
15. Morgello, S., Wolfe, D., Godfrey, E., Feinstein, R., Tagliati, M. & Simpson, D. M. (1995). Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy. Acta Neuropathologica (Berlin) 90, 366-74.
16. Thompson, K. A., McArthur, J. C. & Wesselingh, S. L. (2001). Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Annals of Neurology 49, 745-52.
17. Cossarizza, A., Mussini, C., Mongiardo, N., Borghi, V., Sabbatini, A., DeRienzo, B. et al. (1997). Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome. AIDS 11, 19-26.
18. Plymale, D., Tang, D., Comardelle, A., Fermin, C., Lewis, D. & Garry, R. (1999). Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells. AIDS 13, 1827-39.
19. Griffin, J., Crawford, T., Tyor, W., Glass, J., Price, D., Cornblath, D. et al. (1991). Predominantly sensory neuropathy in AIDS: distal axonal degeneration and unmyelinated fiber loss. Neurology 41, Suppl. 1, 374.
20. Cherry, C., McArthur, J., Costello, K., Woolley, I., Mijch, A. & Wesselingh, S. (2002). Increasing prevalence of neuropathy in the era of highly active antiretroviral therapy (HAART). In Ninth Conference on Retroviruses and Opportunistic Infections, Seattle, WA, USA.
21. Schilling, B. E., Nelson, D. R., Proctor, J. E., Diamond, S. S., Kaul, S. & Hawkins, H. C. (1995). The nonclinical toxicologic profile of stavudine. Current Therapeutic Research 56, 201-18.
22. Tsai, C., Follis, K., Yarnall, M. & Blakley, G. (1989). Toxicity and efficacy of 2′,3′-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2. Antimicrobial Agents and Chemotherapy 33, 1908-14.
23. Hart, A., Terenghi, G., Johnson, M. & Youle, M. (2000). L-Acetyl carnitine therapy increases cutaneous innervation and improves symptoms in antiretroviral related HIV peripheral neuropathy. In First International Workshop on Clinical Pharmacology, Noordwijk, The Netherlands.